We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SAMPO:OMXHEXSampo Oyj Analysis

Data as of 2026-07-25 - not real-time

DKK 71.82

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Sampo Plc A is trading at DKK 71.82, essentially flat around its 20‑day (70.81) and 200‑day (70.80) simple moving averages, with a neutral trend and an RSI of 60.8 indicating modest upward momentum. The MACD histogram has turned slightly negative (bearish) and volume is on a decreasing trajectory, suggesting short‑term pressure as the price approaches the identified resistance at DKK 72.90. The stock’s beta of 0.03 (near‑zero) and 30‑day volatility of 15.35% point to a very low systematic risk but a moderate price swing range.
Fundamentally, revenue has contracted by 7.8% year‑over‑year, yet the company maintains a solid profit margin of 15.6% and a robust ROE of 21.3%. With DKK 18.64 bn in cash versus DKK 2.42 bn of debt (debt‑to‑equity ~29.6%), the balance sheet is strong, though the price‑to‑book of 3.11 signals a premium valuation. The absence of a dividend and a zero payout ratio further limit income‑focused appeal, while the diversified geographic footprint spreads risk across Northern Europe and beyond.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish MACD histogram and decreasing volume
  • Price near resistance with limited upside
  • Revenue contraction signaling near‑term earnings pressure

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Strong ROE and profit margins despite revenue dip
  • Very low beta and ample cash cushion
  • Diversified insurance operations reducing single‑market exposure

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Stable, diversified insurance business across multiple European markets
  • Robust balance sheet with low debt and high liquidity
  • Consistently high profitability metrics supporting sustainable earnings

Key Metrics & Analysis

Financial Health

Revenue Growth-7.80%
Profit Margin15.62%
ROE21.26%
ROA5.18%
Debt/Equity29.55
P/B Ratio3.1
Op. Cash FlowDKK969.0M
Free Cash FlowDKK708.2M

Technical Analysis

TrendNeutral
RSI60.8
SupportDKK 67.60
ResistanceDKK 72.90
MA 20DKK 70.81
MA 50DKK 68.91
MA 200DKK 70.80
MACDBearish
VolumeDecreasing
Fear & Greed Index88.25

Valuation

GradeFair
TypeBlend

Risk Assessment

Beta0.03
Volatility15.35%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.